The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples